Money-saving cefuroxime reduces endophthalmitis

Article

An investigation has revealed that the administration of intracameral cefuroxime reduces endophthalmitis in cataract surgery and has a high clinical and economical impact on prevention for the infection.

An investigation has revealed that the administration of intracameral cefuroxime reduces endophthalmitis in cataract surgery and has a high clinical and economical impact on prevention of the infection.

A quasi-experimental study, conducted by a team led by Dr Gil Rodriguez-Caravaca, Hospital Universitario Fundación Alcorcón, Madrid, Spain, performed cataract surgery on 19463 patients – 6595 patients before October 2005 and 12868 patients after. Each patient received intracameral cefuroxime as the endophthalmitis prophylaxis during cataract surgery.

Endophthalmitis was identified in 44 cases and positive microbiology was found in 29 cases, with the overall cumulative incidence being 0.23 cases per 100 patients.

Cefuroxime prevented endophthalmitis with a 95% confidence interval. It is an economical solution at €1 per dose, with a potential saving of €11777 for every 182 patients treated.

For more information please refer to the Journal of Cataract and Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.